nivolumab
/nɪˈvɒljʊˌmæb/
nivolumab noun: a human IgG4 anti-PD-1 monoclonal antibody, acting as a checkpoint inhibitor, thus allowing activated T cells to attack cancer cells.
Noun
nivolumab (uncountable)
- a human IgG4 anti-PD-1 monoclonal antibody, acting as a checkpoint inhibitor, thus allowing activated T cells to attack cancer cells
Origin of nivolumab
From -l- (“immunomodulating”) + -umab (“human monoclonal antibody”).
Questions about nivolumab
- What does nivolumab mean?
- Nivolumab means a human IgG4 anti-PD-1 monoclonal antibody, acting as a checkpoint inhibitor, thus allowing activated T cells to attack cancer cells.
- What part of speech is nivolumab?
- Nivolumab is a noun.
- How do you pronounce nivolumab?
- Nivolumab is pronounced /nɪˈvɒljʊˌmæb/.
Words near nivolumab in the dictionary
Source and license
Adapted from Wiktionary: nivolumab (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “nivolumab.” Word.ws, https://word.ws/nivolumab. Based on Wiktionary, CC BY-SA 4.0.
